Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban.

Boban, Ana;Lambert, Catherine;Hermans, Cédric
(2016) Case Reports in Hematology — Vol. 2016, p. 2164329 [1-3] (2016)

Files

2016_Boban_Case_Rep_Hematol.pdf
  • Open Access
  • Adobe PDF
  • 455.32 KB
Download

Details

Authors
Abstract
We here present the successful initial treatment and secondary prophylaxis of superficial venous thrombosis secondary to Behçet's disease by a novel anticoagulant drug, rivaroxaban (Xarelto®). To our knowledge, this is the first case of using an oral direct inhibitor of FXa in this setting. Our findings are promising; the outcome was favourable without any adverse effect noted. We propose that the patients with Behçet's disease and venous thrombosis might benefit from the advantages of the new anticoagulant drug.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Boban, A., Lambert, C., & Hermans, C. (2016). Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban. Case Reports in Hematology, 2016, 2164329 [1-3]. https://doi.org/10.1155/2016/2164329 (Original work published 2016)